Publications by authors named "C Holroyde"

Claim this Profile
P
Phase II trial of 5-fluorouracil and leucovorin in combination with interferon-alpha and interleukin-2 for advanced renal cell cancer.
W Kimryn Rathmell, S Bruce Malkowicz, Christopher Holroyde, Will Luginbuhl, David J Vaughn

Am J Clin Oncol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of toremifene in androgen-independent prostate cancer: a Penn cancer clinical trials group trial.
S Stein, B Zoltick, T Peacock, C Holroyde, D Haller

Am J Clin Oncol· June 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of 5-fluorouracil, leucovorin, and interferon alpha 2A (IFN-alpha 2a) in metastatic pancreatic carcinoma: a Penn Cancer Clinical Trials Group (PCCTG) trial.
A K David, D J Vaughn, C P Holroyde, B Armstead, D G Haller

Am J Clin Oncol· February 2000

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paclitaxel plus carboplatin in advanced carcinoma of the urothelium: an active and tolerable outpatient regimen.
D J Vaughn, S B Malkowicz, B Zoltick, R Mick, P Ramchandani, C Holroyde

J Clin Oncol· January 1998

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of 5-fluorouracil, leucovorin, adriamycin, and cisplatin (FLAP) for metastatic gastric and gastroesophageal junction adenocarcinoma. A Penn Cancer Clinical Trial Group and Roswell Park Cancer Institute Community Oncology Research Program Trial.
D J Vaughn, N J Meropol, C Holroyde, D Mintzer, I Nuamah

Am J Clin Oncol· June 1997

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis